| Abstrakt: |
Researchers at Mohammed V University in Rabat conducted a study on non-small cell lung cancer (NSCLC) in Moroccan patients using targeted next-generation sequencing. The study analyzed genetic alterations in 76 NSCLC samples, identifying targetable genetic alterations in genes like EGFR, KRAS, and MET. The research highlighted the importance of next-generation sequencing in identifying actionable mutations in NSCLC patients, emphasizing its value in clinical diagnostic settings. The study also compared the prevalence of mutated genes in Moroccan patients with the Cancer Genome Atlas database, revealing differences in gene mutations between the two populations. [Extracted from the article] |
